is trizepatide a glp-1 Tirzepatide vs. Semaglutide: Which GLP-1

Although a fairly large proportion of patients have reported a number of side effects, particularly at the gastrointestinal level (nausea, vomiting, diarrhoea), these side effects tend to diminish over time and adherence to treatment remains high, with about 5% of patients discontinuing treatment due to side effects

Women using oral contraceptives should consider using a non-oral method or additional contraception for 4 weeks after initiating tirzepatide and for 4 weeks after each dose increase

doi: 10.3390/biomedicines9101360

The Problem With GLP-1 Agonists Among the most concerning claims are reports of gastroparesis, a debilitating condition characterized by stomach paralysis, which can lead to chronic nausea, vomiting, diarrhea, bowel blockages, dangerous malnutrition, and other health issues